Macular detachment after successful intravitreal bevacizumab for myopic choroidal neovascularization

Japanese Journal of Ophthalmology

Volumn 55, Issue 4, 2011, Pages 378-382

  Shimada, Noriaki ^a   Ohno Matsu, Kyoko ^a   Hayashi, Kengo ^a   Yoshida, Takeshi ^a   Tokoro, Takashi ^a   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bevacizumab; Horoidal neovascularization; Macular retinoschisis; Pathologic myopia

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINOSCHISIS; SUBRETINAL NEOVASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; RETINAL DETACHMENT; RETINOSCHISIS; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80955181027     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-011-0034-2     Document Type: Article

References (14)

1. Steidl SM, Pruett RC. Macular complications associated with posterior staphyloma. Am J Ophthalmol. 1997;123:181-7 (Pubitemid 27066773)
2. Curtin BJ. Ocular findings and complications. In: Curtin BJ, editor. The myopias. Philadelphia: Harper & Row; 1985. p. 277- 347
3. Panozzo G, Mercanti A. Optical coherence tomography findings in myopic traction maculopathy. Arch Ophthalmol. 2004;122: 1455-60 (Pubitemid 39336544)
4. Curtin BJ, Karlin DB. Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol. 1971;1:42-53
5. Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia. Br J Ophthalmol. 2007;91:157-60 (Pubitemid 46202862)
6. Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, et al. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol. 2007;91:161-5 (Pubitemid 46202863)
7. Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: Six-month results of a prospective pilot study. Ophthalmology. 2007;114: 2190-6
8. Chang LK, Spaide RF, Brue C, Freund KB, Klancnik JM Jr., Slakter JS. Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. Arch Ophthalmol. 2008;126:941-5 (Pubitemid 352008374)
9. Ikuno Y, Sayanagi K, Soga K, Sawa M, Tsujikawa M, Gomi F, et al. Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: One-year results. Am J Ophthalmol. 2009;147:94-100
10. Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB. Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results. Am J Ophthalmol. 2010; 149:458-64
11. Chan WM, Lai TYY, Liu DTL, Lam DSC. Intravitreal bevacizumab (avastin) for myopic choroidal neovascularization: 1-year results of a prospective study. Br J Ophthalmol. 2009;93: 150-4
12. Chung EJ, Koh HJ. Retinal detachment with macular hole following combined photodynamic therapy and intravitreal bevacizumab injection. Korean J Ophthalmol. 2007;21:185-7
13. Bando H, Ikuno Y, Choi JS, Tano Y, Yamanaka I, Ishibashi T. Ultrastructure of internal limiting membrane in myopic foveoschisis. Am J Ophthalmol. 2005;139:197-9 (Pubitemid 40094867)
14. Shimada N, Ohno-Matsui K, Yoshida T, Sugamoto Y, Tokoro T, Mochizuki M. Progression from macular retinoschisis to retinal detachment in highly myopic eyes is associated with outer lamellar hole formation. Br J Ophthalmol. 2008;92:762-4. (Pubitemid 351839563)